Dr. Mark Gelbert
Mark is a highly skilled executive leader in consumer products and pharmaceutical driven innovation and brand development. He has successfully demonstrated the ability to structure, lead and drive a multi-faceted global R&D organization that develops and launches consumer drugs, cosmetics, nutritional supplements and personal and skin care products. Mark has led the development and implementation of new innovation cultures in both the consumer products and healthcare environment, and has grown innovation leaders in multiple company cultures.
Mark has been responsible for the launch of hundreds of new consumer pharmaceuticals, cosmetics, dietary supplements and personal care products over his career. He has an inherent ability to partner with Marketing, Business Development and Product Supply on brand and product growth strategies, and has a deep expertise in Product Development, Rx-to-OTC Switch, Regulatory Affairs and Clinical Research in the drug development setting.
Mark was most recently Senior Vice President of Global R&D and Switch for Pfizer Consumer Healthcare, and a member of Pfizer’s Senior Leadership Council and the PCH Global Leadership Team. In this role, Mark led all aspects of the Consumer Division’s Global R&D organization. He was responsible for driving and prioritizing the Division’s R&D efforts to effectively bring new products to market for such iconic brands as Advil®, Centrum®, Caltrate®, Robitussin®, ChapStick® and Nexium®. Mark also led all aspects of the Division’s Rx-to-OTC Switch programs, bringing new OTC drug therapies to the market.
Before joining Pfizer, Mark was Vice President of Global R&D for Johnson & Johnson Consumer Health Care. Mark has also held senior R&D positions with P&G, Schering-Plough Healthcare, and Novartis Consumer Healthcare. Mark began his career in Product Development in Procter & Gamble’s Health Care Division. While at P&G, Mark completed his law degree and focused his efforts in Drug Regulatory Affairs. In addition to his law degree, Mark has a BA in Chemistry from Rutgers College, and a MS and PhD in Chemistry from the University of Massachusetts, Amherst.
Mark has held leadership positions in a number of professional organizations including the Consumer Healthcare Products Association, where he was Chair of the Scientific Affairs Committee and a member of the Board of Directors. He is admitted to the Ohio State Bar and the Federal Southern District of Ohio Bar.